| 书目名称 | Safety and Efficacy of Non-Prescription (OTC) Analgesics and NSAIDs |
| 副标题 | Proceedings of the I |
| 编辑 | K. D. Rainsford,M. C. Powanda |
| 视频video | |
| 图书封面 |  |
| 描述 | The availability of analgesics and non-steroidal anti-inflammatory drugs (NSAIDs) sold over-the-counter (OTC) to the public without prescription has become an issue of major concern in recent years. The problem has been highlighted in the UK, USA and other countries because of the continuing high rates of cases of poisoning and the influence of switching from prescription-only status for many NSAIDs to OTC sale brought about, in a large part, by governments and health maintenance organisations (especially in the USA) anxious to save on costs of these drugs. Concern in the UK about poisoning from paracetamol and the appreciable morbidity and mortality from aspirin was such that a major review was initiated in 1996 by the UK government‘s Medicines Control Agency (MCA). Doubtless, many other governments have also undertaken reviews of the safety issues concerning OTC analgesics and NSAIDs. In the UK the situation has culminated in the decision announced in August 1997, as this book was going to press, that the number of tablets/capsules of the solid dosage forms of paracetamol and aspirin would be limited for sale OTe. This decision was essentially based on the need to limit the unit |
| 出版日期 | Conference proceedings 1998 |
| 关键词 | Alzheimer; analgesics; cancer; clinical trial; drug; kinetics; metabolism; pain; pharmacokinetics; research; s |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-94-011-4878-8 |
| isbn_softcover | 978-94-010-6044-8 |
| isbn_ebook | 978-94-011-4878-8 |
| copyright | Springer Science+Business Media New York 1998 |
发表于 2025-3-21 17:55:22
